Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 29 September 1972:
Vol. 177. no. 4055, pp. 1203 - 1205
DOI: 10.1126/science.177.4055.1203
Prev | Table of Contents | Next

Articles

A New, Long-Lasting Competitive Inhibitor of Angiotensin

R. K. Türker 1, M. M. Hall 1, M. Yamamoto 1, C. S. Sweet 1, and F. M. Bumpus 1

1 Research Division, Cleveland Clinic Foundation, Cleveland, Ohio 44106

An analog of angiotensin II, [Sar1, Ile8]-angiotensin II, has a potent and long-lasting competitive antagonistic effect against angiotensin II when tested for its myotropic action on the isolated rabbit aorta and for its effect on blood pressure in anesthetized cats and dogs. Compared to [Ile8]-angiotensin II, the new analog has equal antagonistic potency on the isolated system but a much greater potency in vivo. It is assumed that sarcosine in position 1 protects the peptide against enzymatic degradation and enhances its half-life. This study demonstrates that the modification in both positions 1 and 8 are important for the in vivo antagonistic potencies of angiotensin analogs.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin-angiotensin system.
Y. Asada, T. Yamazawa, K. Hirose, T. Takasaka, and M. Iino (1999)
J. Physiol. 521, 497-505
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)